Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc

Bullboard Posts

Comment by thenightstockeron Jul 01, 2000 4:41am

429 Views

Post# 2144423

RE: CORRECT ME IF I'M WRONG ....PLEASE

Don't worry be Happy Just a little thing i do every once and a while, I go back and review some of the Hype that gets me into these stocks for the long term. Trading around a mere 30 cents, Conac Software [V.COT] is Boaz's penny pick. The company develops financial management systems for the construction and engineering industries, and Boaz has had it among his top holdings for a few months. "It's going to see tremendous growth over the next couple of years. It represents great potential going forward." While the stock has bounced around--from 43 cents in late February to $1.18 in early March and back again--it will easily return to former highs once the market realizes its strong upward growth curve, he says. It is a company that "makes money and will make more money going forward." The upside will stem from contracts in the US, where the company is expanding and where the construction industry is "enormous." Don't worry think long!!!!!!!!!!!! And have one hell of a lonnnnnnggggg weekend

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload